Sorrento Therapeutics (SRNEQ)

Sorrento Therapeutics (SRNEQ) Income Statement


Sorrento Therapeutics Income Statement

Last quarter (Q2 2023), Sorrento Therapeutics's total revenue was $12.61M, an increase of 9.98% from the same quarter last year. In Q2, Sorrento Therapeutics's net income was $-95.21M. See Sorrento Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 56.20M$ 62.84M$ 52.90M$ 39.99M$ 31.43M$ 21.19M
Cost of Revenue
$ 113.42M$ -4.54M$ 13.03M$ 9.94M$ 12.24M$ 7.06M
Gross Profit
$ 9.75M$ 29.68M$ 39.87M$ 30.05M$ 19.20M$ 14.13M
Operating Expense
$ 426.40M$ 407.89M$ 407.92M$ 231.57M$ 214.38M$ 143.61M
Operating Income
$ -416.65M$ -378.21M$ -368.05M$ -201.53M$ -195.18M$ -129.48M
Net Non Operating Interest Income Expense
$ -4.13M$ -8.57M$ -10.22M$ -20.16M$ -35.05M$ -56.71M
Other Income Expense
$ 112.77M$ 128.63M$ -84.26M$ -88.90M$ -129.35M$ -27.59M
Pretax Income
$ -552.86M$ -561.75M$ -462.53M$ -310.58M$ -359.58M$ -213.78M
Tax Provision
$ 9.31M$ -2.42M$ -33.52M$ -2.01M$ -473.00K$ -6.27M
Earnings From Equity Interest Net Of Tax
$ -18.73M$ -18.43M$ -126.00K$ -5.84M$ -3.91M$ -5.02M
Net Income Common Stockholders
$ -548.10M$ -572.84M$ -428.32M$ -298.46M$ -292.07M$ -203.54M
Basic EPS
$ -0.63$ -1.37$ -1.45$ -1.30$ -2.20$ -1.92
Diluted EPS
$ -0.63$ -1.37$ -1.45$ -1.30$ -2.35$ -1.92
Basic Average Shares
$ 1.55B$ 419.31M$ 294.77M$ 229.82M$ 132.73M$ 106.15M
Diluted Average Shares
$ 1.55B$ 419.31M$ 294.77M$ 229.82M$ 140.51M$ 106.15M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 539.82M$ 403.35M$ 420.95M$ 241.51M$ 226.61M$ 150.67M
Net Income From Continuing And Discontinued Operation
$ -563.11M$ -572.84M$ -428.32M$ -298.46M$ -292.07M$ -203.54M
Normalized Income
$ -184.82M-$ -376.02M$ -211.51M$ -163.09M$ -176.90M
Interest Expense
$ 792.00K-$ 10.22M$ 20.16M$ 36.14M$ 57.63M
$ -548.75M$ -553.17M$ -452.30M$ -290.42M$ -323.44M$ -156.15M
$ -517.19M$ -535.70M$ -439.84M$ -279.42M$ -312.45M$ -146.66M
Currency in USD

Sorrento Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis